Toxic epidermal necrolysis is a severe, life-threatening condition where the skin reacts so dramatically that it begins to peel away in sheets, resembling a severe burn injury that can cover much of the body and even affect the eyes, mouth, and other delicate areas.
Understanding Toxic Epidermal Necrolysis
Toxic epidermal necrolysis, often shortened to TEN, represents one of the most serious skin reactions that can happen to a person. This condition causes the outer layer of skin to die and separate from the layers beneath it, leading to widespread blistering and peeling across large portions of the body. When doctors talk about TEN, they are describing a situation where at least 30 percent of the body’s surface is affected by this destructive process. The condition does not just attack the skin on the outside of the body—it also damages the moist inner linings called mucous membranes, which are the protective tissues found inside the mouth, eyes, throat, and genital areas.[1]
The condition sits on a spectrum with another disorder called Stevens-Johnson syndrome. Both conditions involve the same disease process, but they differ in how much of the body they affect. Stevens-Johnson syndrome damages less than 10 percent of the body surface, while TEN affects more than 30 percent. When someone has between 10 and 30 percent of their body involved, doctors consider it an overlap between the two conditions.[2]
What makes TEN particularly dangerous is that when large areas of skin are damaged or lost, the body loses its natural protective barrier. Without intact skin, fluids and salts leak out from the exposed areas, similar to what happens with serious burn injuries. These raw, damaged areas also become easy targets for infections, which can quickly become life-threatening.[3]
Epidemiology
Toxic epidermal necrolysis is considered a rare disease worldwide. When researchers look at how often TEN and Stevens-Johnson syndrome occur together, they find that these conditions affect somewhere between 1 and 2 people per million each year. In the United States specifically, TEN alone occurs in approximately 1.9 people per million adults annually, while Stevens-Johnson syndrome affects about 9.3 per million people per year.[3][4]
The condition can strike people of any age, though it appears to be somewhat more common in older populations. Studies have also shown that TEN affects females more often than males, though the exact reasons for this difference are not completely understood.[5]
Certain groups of people face higher risks of developing TEN. Those with weakened immune systems—whether from HIV infection, cancer treatments, or diseases like lymphoma (a type of blood cancer)—are more vulnerable to this severe skin reaction. People who have HIV and are simultaneously dealing with certain infections appear to have an elevated risk. Additionally, individuals with chronic inflammatory diseases, particularly systemic lupus erythematosus (a disease where the immune system attacks the body’s own tissues), are more likely to develop TEN than the general population.[1][4]
Causes
In the vast majority of cases, toxic epidermal necrolysis happens because the body has an abnormal reaction to certain medications. Experts believe that specific drugs trigger an inappropriate immune response that ultimately causes skin cells to die. The medications most commonly linked to TEN include drugs used to treat gout and kidney stones, medications that control seizures, certain antibiotics, anti-inflammatory pain relievers, and drugs used to treat HIV infection.[1]
Among the antibiotics, sulfonamides (often called sulfa drugs) are frequent culprits. These medications are used to treat bacterial infections. Other antibiotics that have been connected to TEN include penicillins, especially ampicillin and amoxicillin, as well as fluoroquinolones, cephalosporins, and chloramphenicol.[3]
Medications prescribed for epilepsy or seizure disorders also carry risk. These include carbamazepine, phenytoin, phenobarbital, lamotrigine, and valproate. A 2008 European study called Euro-SCAR identified lamotrigine, carbamazepine, and phenytoin among the drugs with particularly high risk for causing TEN.[3]
The medication allopurinol, which is used to treat gout and kidney stones by reducing uric acid levels in the body, has also been frequently implicated in TEN cases. Similarly, certain anti-inflammatory drugs known as oxicam-NSAIDs, including piroxicam and meloxicam, have been associated with this severe reaction.[1][6]
For people living with HIV, some of the medications used to treat the infection itself can trigger TEN. Particularly concerning are drugs in the NNRTI class, such as nevirapine, efavirenz, and etravirine. Other antiviral medications, including oseltamivir and abacavir, have also been linked to the condition.[1][3]
Most commonly, symptoms begin to appear within the first four weeks after starting a new medication, though in some cases the reaction can happen as quickly as 48 hours after re-exposure to a drug that previously caused problems. The timing usually falls somewhere between one and four weeks after beginning treatment.[3][5]
While medications are by far the most common cause, TEN can occasionally be triggered by other factors. Infections have been identified as potential causes, including Mycoplasma pneumoniae (a type of bacteria that causes respiratory infections), hepatitis A, human herpesvirus 7, and cytomegalovirus. In children particularly, infections such as colds, flu, cold sores, and glandular fever can sometimes lead to this severe skin reaction.[3][6]
More recently, cases of TEN have been reported in people with COVID-19, either from the viral infection itself or from medications used during treatment. Vaccinations, particularly the meningococcal vaccine, have also been rarely associated with TEN. In some unusual instances, the condition has been linked to underlying cancers such as hepatocellular carcinoma (liver cancer) or lung cancer.[3]
Despite thorough investigation, there remain cases where doctors cannot identify what triggered the reaction. These are classified as idiopathic, meaning the cause is unknown.[3]
Risk Factors
Several factors can increase a person’s likelihood of developing toxic epidermal necrolysis. Understanding these risk factors helps identify who might be most vulnerable to this dangerous condition.
Having a weakened or compromised immune system stands out as a major risk factor. People living with HIV or AIDS face higher risk, as do those with certain blood cancers like lymphoma. When the immune system is not functioning normally—whether due to disease or because of treatments like chemotherapy—the body may be more prone to developing severe reactions to medications.[1]
Genetics appears to play an important role in determining who develops TEN. Some people inherit genetic variations that affect how their bodies break down and process certain medications. When someone cannot normally metabolize a particular drug, the medication or its breakdown products can accumulate and trigger an abnormal immune response. Specific changes in genes, particularly those in the HLA-B gene family, have been strongly associated with increased risk of TEN. These genes help the immune system recognize foreign substances, and certain variations seem to cause the immune system to react abnormally to medications.[1][4]
Interestingly, some genetic variations that increase TEN risk are more common in certain ethnic groups, which means that particular medications might be riskier for some populations than others. This genetic susceptibility can run in families, so having a close family member who has experienced Stevens-Johnson syndrome or TEN may indicate higher personal risk.[6]
Previous experience with the condition is also a significant risk factor. If someone has already had Stevens-Johnson syndrome or TEN after taking a particular medication, they face a much higher risk of experiencing it again if they take that same medication or chemically similar drugs in the future. This is why doctors maintain careful records of drug reactions and why patients should always inform healthcare providers about any previous severe medication reactions.[6]
People with certain chronic diseases, particularly systemic lupus erythematosus and other autoimmune conditions, have elevated risk. Those who have received bone marrow transplants also appear more susceptible to developing TEN.[4]
Symptoms
Toxic epidermal necrolysis typically does not strike suddenly. Instead, it tends to announce itself with warning signs that might initially seem like a common flu or other minor illness. Understanding these early symptoms and how the condition progresses can be crucial for getting rapid medical attention.
The illness usually begins with what doctors call a prodrome—a set of early symptoms that appear before the main features of the disease. For TEN, this prodrome looks very much like influenza. People may experience fever and chills, often with temperatures climbing noticeably high. Body aches and muscle pain are common, as are headaches. A cough may develop, and the person might feel generally unwell with decreased appetite and profound tiredness or malaise (a feeling of overall discomfort and illness). The eyes often become red and inflamed during this early stage.[1][5]
A few days after these flu-like symptoms begin, the skin starts to show signs of trouble. A rash appears, often starting with circular patches that may be darker in the middle and lighter around the edges. These initial skin changes can appear on the upper body, particularly the face and chest, before spreading rapidly to other areas including the arms, legs, and eventually the genitals. Unlike many rashes, this one is typically not itchy.[6]
What happens next is what makes TEN so dangerous and distinctive. The skin begins to blister and then peel away in sheets, rather than in small flakes. The blisters may form on top of the red patches, and when they burst or when the skin peels, they leave behind raw, painful areas called erosions. These erosions look remarkably similar to severe burn injuries. The skin often becomes so fragile that it peels very easily with even gentle touch.[2][6]
The damage extends beyond the skin’s surface. The mucous membranes—those moist linings inside the body—become extensively damaged. Inside the mouth, blisters and sores develop on the lips, tongue, and throat, making swallowing extremely painful and difficult. The person may struggle to eat or drink anything. Similar damage occurs in the nose and airways, which can affect breathing.[1]
The eyes suffer significant involvement in TEN. The conjunctiva (the thin membrane that covers the white part of the eye and lines the inside of the eyelids) becomes inflamed and may develop erosions. The cornea (the clear outer lens of the eye) can also be damaged. These changes cause severe eye pain, redness, and sensitivity to light, making it difficult and painful to look at bright lights. Vision problems may develop, and without proper care, permanent eye damage can occur.[1]
The genital and urinary areas are frequently affected as well. Blisters and erosions can develop on the genitals, around the anus, and in the urethra (the tube that carries urine out of the body). This makes urination painful and difficult. In severe cases, these areas may develop complications that can have long-lasting effects.[1][6]
As the condition progresses and more skin is lost, the body’s normal functions become increasingly compromised. The extensive skin damage allows fluids, salts, and proteins to leak from the body, similar to what happens with major burn injuries. The person may become dehydrated. The raw, exposed areas are vulnerable to bacterial infections, which can spread into the bloodstream. Temperature regulation becomes difficult, and the person may feel cold because the damaged skin cannot maintain normal body temperature.[9]
Complications
The complications of toxic epidermal necrolysis can be severe and life-threatening. The extensive loss of skin creates multiple serious problems for the body.
Infections represent one of the most dangerous complications. When large areas of skin are damaged or missing, bacteria and other microorganisms can easily enter the body. These infections can remain localized in the skin, but they can also spread into the bloodstream, causing sepsis—a life-threatening condition where the body’s response to infection causes widespread inflammation and can lead to organ failure and death.[1]
Pneumonia, an infection of the lungs, develops frequently in people with TEN, particularly when the airways and respiratory tract have been damaged by the disease. This makes breathing even more difficult and adds to the body’s overall stress.[1]
The loss of large amounts of fluid through damaged skin can lead to severe dehydration and imbalances in the body’s salts and minerals, called electrolytes. These imbalances can affect how the heart beats, how muscles work, and how well the kidneys function. If not corrected promptly, they can be fatal.[9]
Multiple organ failure can occur when the stress on the body becomes too great. The kidneys may stop working properly, the liver may fail, and the heart may struggle to pump effectively. When multiple organs fail simultaneously, survival becomes increasingly difficult even with intensive medical support.[1]
For those who survive TEN, long-term complications can persist for months or even permanently. Skin changes are common, including areas of abnormal coloring or pigmentation, excessive dryness called xerosis, or areas that sweat more than normal, known as hyperhidrosis. Hair loss can occur, and fingernails and toenails may grow abnormally or be lost entirely.[4]
Eye complications can be particularly troublesome long-term. Chronic dryness or ongoing inflammation of the eyes may persist, leading to increased sensitivity to light and vision problems. Some people develop permanent eye damage that affects their sight.[4]
The sense of taste may be permanently impaired. Problems with urination can continue, and genital abnormalities may develop, particularly if the urinary tract and genital areas were severely affected during the acute illness.[4]
Prevention
Preventing toxic epidermal necrolysis centers primarily on careful medication management and awareness of personal risk factors.
The most important preventive measure for someone who has previously experienced Stevens-Johnson syndrome or TEN is to permanently avoid the medication that caused it, as well as any chemically related drugs. Even a small dose of the offending medication can trigger another episode, often more severe than the first. People who have had these reactions should wear medical alert jewelry indicating their drug allergies and should inform all healthcare providers—including dentists, pharmacists, and emergency personnel—about their history.[2][6]
For individuals from ethnic groups known to have higher rates of genetic variations associated with TEN risk, genetic testing may be available before starting certain high-risk medications. This testing can identify people who carry genes that make them more susceptible to severe reactions to specific drugs. If the testing reveals high-risk genes, alternative medications can be chosen.[4]
When starting a new medication known to carry risk for TEN, particularly drugs like allopurinol, certain antibiotics, or anti-seizure medications, both patients and healthcare providers should maintain high awareness during the first few weeks of treatment. This is when reactions are most likely to occur. Any development of fever, rash, mouth sores, or other concerning symptoms should prompt immediate medical evaluation.[3]
For people with weakened immune systems, extra caution is warranted when starting new medications. Healthcare providers may choose to monitor these patients more closely or select alternative treatments when possible. Those with HIV, cancer, or autoimmune diseases should discuss their increased risk with their doctors when new medications are prescribed.[1]
There is no vaccine or specific preventive medication that can protect against TEN. The key is awareness, careful medication selection, appropriate monitoring, and immediate action if warning symptoms appear. Healthcare providers play a crucial role by considering a patient’s risk factors before prescribing high-risk medications and educating patients about what symptoms to watch for.[6]
Pathophysiology
Understanding what happens in the body during toxic epidermal necrolysis helps explain why the condition is so severe and why it produces such dramatic effects on the skin.
At the cellular level, TEN involves the widespread death of skin cells called keratinocytes, which make up the bulk of the outermost layer of skin, known as the epidermis. This cell death, or necrosis, causes the epidermis to separate from the underlying layer of skin called the dermis. When this separation happens across large areas of the body, it results in the characteristic blistering and peeling seen in TEN.[3]
The exact mechanism by which medications trigger this process is not completely understood, but researchers have identified several important pieces of the puzzle. The current theory suggests that in susceptible individuals, certain drugs or their metabolic breakdown products interact with the immune system in abnormal ways. Rather than simply being processed and eliminated from the body, these substances trigger an excessive immune response targeted at the skin.[4]
The immune system’s T cells, particularly a type called CD8+ T cells, appear to play a central role in attacking the skin. These immune cells release substances that kill keratinocytes. One particularly important substance is called granulysin, which is found in very high concentrations in the fluid from TEN blisters. The amount of granulysin correlates with how severe the disease becomes—more granulysin means worse disease.[13]
Another immune system messenger called interleukin-15 has been found at elevated levels in people with TEN. This substance appears to stimulate the production of even more granulysin, creating a destructive cycle that propagates the damage.[13]
Researchers have also identified another mechanism involving a protein called Fas and its partner molecule, Fas ligand. When these molecules interact on the surface of keratinocytes, they can trigger a form of programmed cell death called apoptosis. In TEN, elevated levels of soluble Fas ligand (a form released from immune cells) may contribute to widespread keratinocyte death.[13]
The genetic component of TEN relates to how individuals process medications. The HLA-B gene, which is part of the body’s system for recognizing foreign substances, comes in many variations. Certain versions of this gene appear to cause the immune system to misidentify certain medications as dangerous threats, triggering the aggressive immune attack on skin cells. Different HLA-B variations are associated with reactions to different drugs, which explains why some people react to certain medications while others do not.[4]
When the epidermis separates from the dermis, the body loses its primary barrier against the outside world. This leads to massive fluid loss, similar to what occurs with severe burns. The damaged skin can no longer prevent water and salts from evaporating or leaking out. Proteins are also lost through the damaged areas. The breakdown of the skin barrier allows bacteria and other microorganisms to enter, setting the stage for potentially deadly infections.[9]
The body’s temperature regulation system depends heavily on intact skin. When large areas of skin are damaged, the body cannot maintain normal temperature effectively, and patients often struggle with hypothermia even in warm environments. The loss of skin also means loss of pain and touch sensation in affected areas, though the process of skin damage itself is extremely painful.[10]
